|
Market Cap (25-Jun) $125,067,280 (1,258th) |
Close (30-Jun) $0.007 |
Volume (30-Jun) 188,484 |
Shortsold (14-May) 14,985,846 (0.14%) (426th) |
|
52w High $0.85 |
52w Low $0.350 |
P/E 10.33 |
EPS -0.07 |
ATH released this announcement to the ASX on 20 June 2022, 9:04. The announcement is not marked as price sensitive, and is 2 page(s) in length and 137.17kb in size.
You can view all announcements from ATH and see how they appear on a price chart on the announcements page.
At the date of this announcement, ATH was 0.001% short sold according to ASIC data. It was ranked the 636th most shorted stock on the ASX. It is now ranked as the 426th most shorted stock on the ASX with 0.138% of total shares short sold as of the latest reported data (14 May 2026).
| Other Recent Announcements from ATH | |
|---|---|
| Investor Presentation | 22 June 2023, 11:13 |
| ATH to present at MST Rare Diseases Rich Returns Forum | 21 June 2023, 9:52 |
| ATH starts 2nd Phase 2 Study in Rare Parkinsonian Disorder | 30 May 2023, 13:32 |
| Alterity to Present at Life Sciences Investor Forum | 20 June 2022, 9:04 |
| Alterity to present at GCFF Virtual Conference 2022 | 14 June 2022, 14:33 |
| Alterity Launches ATH434 Phase 2 Clinical Trial | 2 June 2022, 9:59 |
| Alterity to Participate in the Benchmark Company Conference | 26 May 2022, 12:35 |
You must be logged in to post a reply.
Alterity Therapeutics 